HomeNews

News

Global Markets

Viatris and Biocon Biologics launch Abevmy, oncology biosimilar, in Canada

Pharma -
Viatris Inc. and Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced May 19th, that Abevmy® (bevacizumab) is now available in Canada. Abevmy, co-developed...
Global Markets

Amazon and Walmart’s Flipkart in talks to buy a stake in diagnostic chain Metropolis Healthcare

Pharma -
Metropolis Metropolis Healthcare Ltd., a diagnostics chain operating in India and Africa, is looking to raise more than $300 million and bring on board...
Global Markets

Laekna’s next-generation medications raise $61 million

Pharma -
Laekna Therapeutics ("Laekna"), a clinical-stage global biotechnology company dedicated to developing next generation medicines to treat cancer and liver diseases, announced that it has...
Drug Development

Open Orphan signs a £7.3 million contract for influenza human challenge study

Pharma -
Open Orphan PLC said Wednesday that its hVIVO subsidiary has signed a 7.3 million pounds ($9.1 million) influenza human challenge study contract with an...
Global Markets

Tonix Pharmaceuticals announces reverse stock split, shares fall again

Pharma -
Tonix Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that it will effect a 1-for-32 reverse stock split of its outstanding common stock. This will be...
Global Markets

Startup RQ Biotechnology received $157 million from AstraZeneca for Covid antibodies

Pharma -
RQ Bio emerges from stealth mode announcing its launch as a new UK-based biotechnology company following the completion of a successful licensing deal with...
1...262728...117Page 27 of 117
spot_img

Expert Articles

spot_img